Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.03 | 15322242 14514962 11752688 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
8.03 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.84 | 19490988 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
8.80 | 16538975 |
MESH:D058186 |
Acute Kidney Injury |
|
zoledronic acid |
8.80 | 19715164 |
MESH:D000210 |
Acute-Phase Reaction |
|
zoledronic acid |
5.40 | 20200999 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
10.02 | 20464547 20127859 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
10.02 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
10.02 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
10.02 | 11473722 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
6.63 | 6695378 |
MESH:D000236 |
Adenoma |
|
resveratrol |
6.63 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.29 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.62 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.82 | 16712894 17306315 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.46 | 21441931 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.54 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
2.55 | 16183991 16162502 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.15 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.87 | 11748828 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.50 | 17497229 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.99 | 19183758 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
7.33 | 17115116 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
7.33 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.24 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.32 | 16456186 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
3.22 | 17967414 16873680 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.01 | 18177632 18985861 18940202 18316065 20603192 17688650 16609825 17507914 18775368 18558336 19232924 19460635 17157402 18396377 15238991 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.32 | 16935849 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.03 | 17594078 20046352 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.66 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
8.66 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.71 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
7.83 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
7.83 | 8888407 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.62 | 14601052 |
MESH:D001859 |
Bone Neoplasms |
|
zoledronic acid |
4.87 | 19442620 15867366 17312309 16778634 16121404 11697798 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
9.52 | 11985600 |
MESH:D001862 |
Bone Resorption |
|
zoledronic acid |
9.52 | 18404659 8053405 16769263 15845617 18496637 11869084 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.26 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.17 | 15665606 15845082 15380490 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
4.20 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.73 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
6.95 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
6.95 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
6.95 | 19526202 18234424 16264153 17983394 16096432 15994142 11325840 15692762 16115903 15567936 15668708 17426702 18628466 16826403 18695136 16322301 15136595 16935488 16595493 17369602 15634643 15993339 15939500 18382427 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
6.95 | 18497071 19861407 12948864 16675129 14630087 17261762 17018787 17289903 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
6.95 | 17200150 16873071 16541309 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
6.95 | 16175315 17614352 15562024 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
6.95 | 16393696 17651959 17534123 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
6.95 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
6.95 | 16873071 16443354 16166294 |
MESH:D001943 |
Breast Neoplasms |
|
zoledronic acid |
6.95 | 18695136 16096432 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.50 | 16813970 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.38 | 16111702 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.73 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.73 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.08 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
13.89 | 21507988 12907637 12619106 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
13.89 | 16023760 18059187 17876044 16234567 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
13.89 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
13.89 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
13.89 | 19321006 16227395 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
13.89 | 16507464 17306315 15276417 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
13.89 | 1917145 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.90 | 17123778 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.51 | 16675471 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
zoledronic acid |
3.51 | 19233551 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
10.81 | 1485588 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Vinblastine |
10.81 | 1485588 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
zoledronic acid |
10.81 | 18507039 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
14.07 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
14.07 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
14.07 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
14.07 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
14.07 | 16051514 16096774 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.32 | 16120746 18850075 18670907 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.47 | 17131338 17974986 16651473 16731534 17519947 16278810 17351982 15792986 17329180 16952015 16364871 17924179 15476868 15811867 16242529 17382496 15505089 17928571 16109756 17007740 18627295 16612575 16455267 17308081 16269455 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.92 | 16243910 17334414 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
7.31 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
7.31 | 15458977 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.04 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
20.46 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
20.46 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cytarabine |
20.46 | 8243401 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
20.46 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
20.46 | 19524636 20056578 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.50 | 16129372 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.68 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.08 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
2.85 | 19486331 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.08 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.64 | 15668235 12621046 16354765 8697196 15340226 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.64 | 9407595 |
MESH:D003092 |
Colitis |
|
resveratrol |
9.34 | 16474422 |
MESH:D003092 |
Colitis |
|
Tretinoin |
9.34 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
3.88 | 17182828 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
3.88 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
4.83 | 18259882 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
Polychlorinated Biphenyls |
4.83 | 15531428 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
4.83 | 16550006 |
MESH:D015179 |
Colorectal Neoplasms |
|
Vinblastine |
4.83 | 18802399 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.98 | 14669216 17141729 |
MESH:D003327 |
Coronary Disease |
|
fluvastatin |
8.71 | 16142594 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
8.71 | 16507316 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.71 | 20055451 10048152 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
3.71 | 9125849 16925845 9211117 10589399 14991402 17551590 9664655 8800419 9224671 9142499 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
3.71 | 17688650 16575769 8888407 |
MESH:D003704 |
Dementia |
|
Polychlorinated Biphenyls |
4.62 | 16140633 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.69 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
4.26 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.26 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
8.76 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
8.76 | 16286809 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.41 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
6.11 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.11 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
6.11 | 1733752 19641884 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
7.89 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
7.89 | 11462148 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
3.96 | 1851702 |
MESH:D004487 |
Edema |
|
resveratrol |
6.59 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.59 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
11.67 | 16714409 18230668 15322242 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
11.67 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
9.06 | 17692515 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
9.06 | 17872969 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
4.50 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
17.32 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
17.32 | 18566989 11473722 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
17.32 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
17.32 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
8.66 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
8.66 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.08 | 18037988 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.76 | 17923197 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.07 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.84 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.89 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.51 | 7562514 6426943 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.21 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
3.98 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.27 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.27 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.61 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.61 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
7.49 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
7.49 | 14986274 19224547 |
MESH:D005264 |
Femoral Fractures |
|
zoledronic acid |
5.74 | 16234978 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.37 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.81 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.04 | 8888407 18558336 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.50 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
14.22 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
14.22 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
14.22 | 17994277 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.59 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.13 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
11.60 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
11.60 | 16598420 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
11.60 | 17312396 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.51 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
7.65 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
7.65 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.08 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
10.82 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
10.82 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
10.82 | 14991402 9664655 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.42 | 17888722 16879835 16244372 16244371 16330681 18674790 16707910 14766674 12587719 16495754 16144979 18006777 17875725 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.29 | 17481944 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.82 | 15692506 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.34 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.25 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.81 | 15340226 12621046 16120746 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.95 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
4.09 | 16876885 |
MESH:D006689 |
Hodgkin Disease |
|
Cytarabine |
16.94 | 16200630 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
16.94 | 18501091 17606976 15147373 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
16.94 | 12676792 |
MESH:D006689 |
Hodgkin Disease |
|
Vinblastine |
16.94 | 18180244 18501091 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.67 | 17088409 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.78 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.96 | 16959395 8697196 18606429 15340226 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
7.96 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
zoledronic acid |
7.96 | 16769263 |
MESH:D006934 |
Hypercalcemia |
|
zoledronic acid |
4.96 | 19622757 18089816 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
3.92 | 17188708 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.48 | 16778211 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
3.94 | 16873680 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.83 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.83 | 18850075 18670907 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.22 | 17488730 |
MESH:D006996 |
Hypocalcemia |
|
zoledronic acid |
6.11 | 12669777 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
11.20 | 15869954 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
11.20 | 17600658 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
2.93 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
Progesterone |
8.10 | 15869954 |
MESH:D007249 |
Inflammation |
|
resveratrol |
8.10 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
8.10 | 12878042 12200463 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
4.46 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
7.24 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
7.24 | 16393666 16627594 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.68 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.66 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
9.66 | 15992940 17551590 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.36 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
14.04 | 18776723 10903974 8314463 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
14.04 | 16775033 15699352 15369732 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
14.04 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
14.04 | 20008137 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.07 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.03 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
7.03 | 15610895 |
MESH:D007938 |
Leukemia |
|
Genistein |
6.27 | 18980019 17468513 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
6.27 | 17143497 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.08 | 16085563 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
zoledronic acid |
4.69 | 18089816 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.62 | 16932348 16482212 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
3.83 | 16294345 19850784 17596541 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
3.83 | 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
7.57 | 16087638 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
7.57 | 17649720 17506722 16788101 19029980 17712046 19225113 17107899 12679006 17339181 17301526 19075265 16935935 17294898 15748426 19642359 16331271 19035177 17368321 16140955 16766008 17361223 17217047 9834237 16891316 16823087 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.24 | 9224671 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
6.63 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
6.63 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
6.63 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
6.63 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
6.63 | 18397230 16248980 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
13.89 | 18177683 9163691 2125692 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
13.89 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
13.89 | 19812893 20405173 19073162 19321006 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
13.89 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
13.89 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
13.72 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
13.72 | 17085340 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Polychlorinated Biphenyls |
13.72 | 1423854 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
13.72 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.11 | 19095001 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.18 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
6.47 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
6.47 | 18569708 20869020 20464547 20135361 18816296 18520028 6695378 17053015 20064080 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
6.47 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
6.47 | 16712894 17077188 17306315 15276417 19931552 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
6.47 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.40 | 16098063 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
4.21 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
8.63 | 17654614 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
8.63 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.48 | 15621674 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
4.16 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
22.86 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
22.86 | 17203775 11408345 16891317 11807958 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
22.86 | 14578162 12929590 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
22.86 | 17203775 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
22.86 | 8985016 11606380 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
zoledronic acid |
22.86 | 17312309 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.40 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.75 | 17453147 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
9.66 | 16827129 |
MESH:D008545 |
Melanoma |
|
resveratrol |
9.66 | 17992120 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
9.66 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
9.66 | 16752155 |
MESH:D008545 |
Melanoma |
|
Vinblastine |
9.66 | 15577320 18332650 15577323 18505091 18176117 16432458 17761969 12374674 16248763 16809738 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.34 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
6.53 | 17638057 |
MESH:D008654 |
Mesothelioma |
|
zoledronic acid |
6.53 | 16675582 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.29 | 17112576 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.71 | 16801185 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.13 | 18765137 18803445 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.42 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.12 | 16381670 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.70 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
fluvastatin |
12.10 | 16996129 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
12.10 | 14749477 16267019 17049120 16490592 17935668 17164350 |
MESH:D009101 |
Multiple Myeloma |
|
zoledronic acid |
12.10 | 16996129 18089719 19621390 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.78 | 17962980 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.94 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
7.23 | 17596541 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
7.23 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
9.39 | 15857846 19429709 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
9.39 | 17141266 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
9.39 | 16456233 16317513 17015251 16525036 17125593 17188708 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
8.77 | 17015251 17125593 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
8.77 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
8.28 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
8.28 | 17141266 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.67 | 17322642 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
6.16 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
zoledronic acid |
6.16 | 19139120 17312309 15867366 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
8.01 | 11141357 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
8.01 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
8.01 | 16594593 16946489 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
8.94 | 8985016 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
8.94 | 20056578 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.65 | 17289903 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.68 | 16636307 16899518 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.36 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
9.04 | 18481113 19348381 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
9.04 | 16889571 15640375 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
29.83 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
29.83 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
29.83 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
29.83 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
29.83 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
11.82 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
11.82 | 9142499 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
11.82 | 16359493 8888407 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.22 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
3.73 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
4.31 | 17929310 |
MESH:D009503 |
Neutropenia |
|
Vinblastine |
4.49 | 17378895 |
MESH:D010014 |
Osteolysis |
|
zoledronic acid |
5.28 | 15867366 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
7.39 | 19401787 |
MESH:D010024 |
Osteoporosis |
|
zoledronic acid |
7.39 | 17882678 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
9.87 | 16169203 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
9.87 | 17513867 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.04 | 15930896 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.90 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
14.69 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
14.69 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
14.69 | 17393432 16525653 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
14.69 | 17306315 15276417 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
14.69 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
6.91 | 16870215 |
MESH:D010146 |
Pain |
|
zoledronic acid |
6.91 | 16475674 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.43 | 15976015 |
MESH:D010300 |
Parkinson Disease |
|
Polychlorinated Biphenyls |
3.36 | 16702228 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.17 | 12520081 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.08 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.08 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.47 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.14 | 12371664 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cytarabine |
4.39 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
22.56 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
22.56 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
22.56 | 11118676 11399792 11896295 11222880 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
22.56 | 20603192 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
10.28 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
10.28 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.94 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.94 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.94 | 15749863 15897917 16868541 16729912 16888761 18437689 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.94 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
2.94 | 15378649 16925846 15256057 |
MESH:D011471 |
Prostatic Neoplasms |
|
Polychlorinated Biphenyls |
2.94 | 15721890 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
2.94 | 17675339 15767336 17804756 17636462 16731767 17718901 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.94 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
zoledronic acid |
2.94 | 12438248 19103299 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.52 | 16636307 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.46 | 11422049 12752131 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.20 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.71 | 16723453 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.70 | 10548101 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.13 | 17922066 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.50 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
3.23 | 17520802 15827377 16314181 16317513 17058453 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.75 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
10.58 | 16116481 16283617 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
10.58 | 19155313 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.83 | 18045962 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.91 | 17203757 15625365 18313854 16767912 17710206 15675481 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
10.35 | 16326096 14601052 |
MESH:D012512 |
Sarcoma, Ewing's |
|
zoledronic acid |
10.35 | 16121404 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.70 | 17846226 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.06 | 19110320 15737665 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.68 | 14763951 15475178 1511512 11738929 11044598 16876388 3137016 17978042 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
21.95 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
21.95 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
21.95 | 15837718 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
21.95 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
21.95 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
21.95 | 16467112 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.48 | 17203757 15625365 16767912 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.19 | 16503802 15862959 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
9.31 | 12854658 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
9.31 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.46 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.32 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.32 | 17261132 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.40 | 16321402 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.90 | 16684133 16045194 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.82 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
7.08 | 16010429 17909728 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
7.08 | 17045167 16026305 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.60 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
9.65 | 16227395 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
9.65 | 16051514 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.15 | 17262798 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.17 | 16040207 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.44 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
8.16 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
8.16 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
8.16 | 17306315 11723127 16452187 16712894 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.56 | 8888407 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
15.43 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
15.43 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
15.43 | 16129372 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.93 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
4.05 | 17044934 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.53 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.90 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Vinblastine |
4.96 | 15577323 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.34 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.51 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
10.05 | 17334414 16364871 17678736 17638931 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
10.05 | 17488730 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.97 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.17 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.89 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.36 | 17120751 |